| COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1236 | 2020 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 650 | 2020 |
| COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing T Peto, D Affron, B Afrough, A Agasu, M Ainsworth, A Allanson, K Allen, ... EClinicalMedicine 36, 2021 | 196 | 2021 |
| A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2 DA Mistry, JY Wang, ME Moeser, T Starkey, LYW Lee BMC infectious diseases 21 (1), 1-14, 2021 | 107 | 2021 |
| A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals P Demetriou, E Abu-Shah, S Valvo, S McCuaig, V Mayya, A Kvalvaag, ... Nature immunology 21 (10), 1232-1243, 2020 | 93 | 2020 |
| Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study LYW Lee, T Starkey, MC Ionescu, M Little, M Tilby, AR Tripathy, ... The Lancet Oncology 23 (6), 748-757, 2022 | 85 | 2022 |
| The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 I Anil, R Arnold, S Benkwitz-Beford, S Branford, N Campton, JB Cazier, ... The Lancet Oncology 21 (5), 622-624, 2020 | 70 | 2020 |
| COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study LYW Lee, MC Ionescu, T Starkey, M Little, M Tilby, AR Tripathy, ... European Journal of Cancer 175, 1-10, 2022 | 40 | 2022 |
| Association of SARS-CoV-2 spike protein antibody vaccine response with infection severity in patients with cancer: a national COVID cancer cross-sectional evaluation LYW Lee, M Tilby, T Starkey, MC Ionescu, A Burnett, R Hattersley, S Khan, ... JAMA oncology 9 (2), 188-196, 2023 | 25 | 2023 |
| Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients R Suribhatla, T Starkey, MC Ionescu, A Pagliuca, A Richter, LYW Lee British Journal of Haematology, 2023 | 24 | 2023 |
| Serum-and glucocorticoid-induced kinase Sgk1 directly promotes the differentiation of colorectal cancer cells and restrains metastasis LYW Lee, C Woolley, T Starkey, S Biswas, T Mirshahi, C Bardella, ... Clinical Cancer Research 25 (2), 629-640, 2019 | 23 | 2019 |
| Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review Y Al Hajji, H Taylor, T Starkey, LYW Lee, M Tilby British Journal of Cancer 127 (10), 1827-1836, 2022 | 21 | 2022 |
| Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? OJ Pickles, LYW Lee, T Starkey, L Freeman-Mills, A Olsson-Brown, ... British journal of cancer 123 (5), 691-693, 2020 | 19 | 2020 |
| Utility of COVID-19 screening in cancer patients LYW Lee, T Hill, O Topping, M Tilby, M Baker, J Greig, L Isherwood, ... Cancer cell 38 (3), 306-307, 2020 | 14 | 2020 |
| CD2 expression acts as a quantitative checkpoint for immunological synapse structure and T-cell activation P Demetriou, E Abu-Shah, S McCuaig, V Mayya, S Valvo, ... Biorxiv, 589440, 2019 | 13 | 2019 |
| Transcriptomics identify a unique intermittent hypoxia-mediated profile in obstructive sleep apnea CD Turnbull, LYW Lee, T Starkey, D Sen, J Stradling, N Petousi American Journal of Respiratory and Critical Care Medicine 201 (2), 247-250, 2020 | 12 | 2020 |
| A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP) T Starkey, MC Ionescu, M Tilby, M Little, E Burke, MW Fittall, S Khan, ... Scientific Reports 13 (1), 11327, 2023 | 9 | 2023 |
| Systematic review of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of covid-19 in immunocompromised patients R Suribhatla, T Starkey, MC Ionescu, A Pagliuca, A Richter, LYW Lee MedRxiv, 2022.11. 07.22281786, 2022 | 6 | 2022 |
| ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study LYW Lee, T Starkey, S Sivakumar, S Fotheringham, G Mozolowski, ... Cancer Medicine 8 (14), 6305-6314, 2019 | 5 | 2019 |
| STAT3 cyclic oligonucleotide decoy—a new therapeutic avenue for NSCLC? LYW Lee, S Mohammad, T Starkey, SM Lee Translational lung cancer research 7 (Suppl 4), S381, 2018 | 4 | 2018 |
